Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | T343J | — |
an expired dose of Kinrix was administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number T343J, expiry date 25-JAN-2025) for prophylaxis. On 11-APR-2025, the patient received Kinrix. On 11-APR-2025, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: an expired dose of Kinrix was administered). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-APR-2025 The nurse reported that an expired dose of Kinrix was administered, which led to expired vaccine used